Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 27, 2021 Filed Jul 28, 2021 16:18 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionCommon Stock | 6,111 | $61.23 | $374,145.98 |
DisclosureSEC source: 0001022079-21-000113 · wf-form4_162750349054685.xml · nonDerivative · entry 3 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 16:18 UTC |
WILENSKY GAIL RDirector
|
SaleCommon Stock | 6,111 | $139.32 | $851,402.85 |
DisclosureSEC source: 0001022079-21-000113 · wf-form4_162750349054685.xml · nonDerivative · entry 2 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,845 F1 · price: This transaction was executed in multiple trades at prices ranging from $139.28 to $139.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 16:18 UTC |
WILENSKY GAIL RDirector
|
Exercise / conversionCommon Stock | 6,111 | $57.57 | $351,779.72 |
DisclosureSEC source: 0001022079-21-000113 · wf-form4_162750349054685.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 20:21 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 32,788 | $95.80 Strike: $95.80 | $3,140,926.46 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · derivative · entry 6 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,244 Underlying: Common Stock · 32,788 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 20:21 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
SaleCommon Stock | 32,788 | $140.01 | $4,590,549.52 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · nonDerivative · entry 4 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,427 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $140.00 to $140.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 20:21 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionCommon Stock | 32,788 | $95.80 | $3,140,926.46 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · nonDerivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 20:21 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 5,813 | $95.80 Strike: $95.80 | $556,856.34 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · derivative · entry 5 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,032 Underlying: Common Stock · 5,813 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 20:21 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
SaleCommon Stock | 5,813 | $140.03 | $813,994.39 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,427 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. Read SEC document |
| July 26, 2021 Filed Jul 28, 2021 20:21 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionCommon Stock | 5,813 | $95.80 | $556,856.34 |
DisclosureSEC source: 0001022079-21-000115 · wf-form4_162750365363041.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 28, 2021. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:36 UTC |
RING TIMOTHY MDirector
|
GrantPhantom Stock Units · Derivative | 313 | $132.52 Strike: $0.00 | $41,478.76 |
DisclosureSEC source: 0001022079-21-000103 · wf-form4_162560376749724.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,999.945 Underlying: Common Stock · 313 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| May 25, 2021 Filed May 25, 2021 20:44 UTC |
Lassiter Wright IIIDirector
|
GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000093 · wf-form4_162197542300450.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,281 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 25, 2021 Filed May 25, 2021 16:46 UTC |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000094 · wf-form4_162197554181992.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,845 F1 · security: Represents an award of restricted share units. Read SEC document |
| May 25, 2021 Filed May 25, 2021 20:50 UTC |
PFEIFFER GARY MDirector
|
GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000096 · wf-form4_162197577446252.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,265 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 25, 2021 Filed May 25, 2021 20:48 UTC |
RING TIMOTHY MDirector
|
GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000095 · wf-form4_162197566755164.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,234 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 25, 2021 Filed May 25, 2021 20:42 UTC |
MAIN TIMOTHY LDirector
|
GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000092 · wf-form4_162197533662523.xml · nonDerivative · entry 1 MAIN TIMOTHY L · CIK 0001196744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,951 F1 · security: Represents an award of restricted share units. Read SEC document |
| May 25, 2021 Filed May 25, 2021 20:41 UTC |
Torley HelenDirector
|
GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000091 · wf-form4_162197523887689.xml · nonDerivative · entry 1 Torley Helen · CIK 0001528185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,260 F1 · security: Represents an award of restricted share units. Read SEC document |
| May 25, 2021 Filed May 25, 2021 20:37 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000089 · wf-form4_162197500311313.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,206 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:39 UTC |
Gregg Vicky BDirector
|
GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000090 · wf-form4_162197510268433.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,400 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes approximately 193 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:26 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 5 | $136.60 | $683.00 |
DisclosureSEC source: 0001022079-21-000079 · wf-form4_162154236496004.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,859 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. F3 · balance_after: The amount includes approximately 59 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:27 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
SaleCommon Stock | 8,536 | $139.96 | $1,194,724.17 |
DisclosureSEC source: 0001022079-21-000077 · wf-form4_162076480079936.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,729 F1 · price: This transaction was executed in multiple trades at prices ranging from $139.56 to $140.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:32 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 44,939 | $71.17 Strike: $71.17 | $3,198,308.63 |
DisclosureSEC source: 0001022079-21-000075 · wf-form4_162041954916213.xml · derivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,939 shares Expires 2025-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2020. F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018. Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:32 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 44,939 | $137.00 | $6,156,643.00 |
DisclosureSEC source: 0001022079-21-000075 · wf-form4_162041954916213.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,152 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2020. Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:32 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionCommon Stock | 44,939 | $71.17 | $3,198,308.63 |
DisclosureSEC source: 0001022079-21-000075 · wf-form4_162041954916213.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2020. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:43 UTC |
RING TIMOTHY MDirector
|
GrantPhantom Stock Units · Derivative | 325.79 | $128.47 Strike: $0.00 | $41,852.61 |
DisclosureSEC source: 0001022079-21-000062 · wf-form4_161739615371653.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,638.791 Underlying: Common Stock · 325.79 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 21:31 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 5,574 | $120.47 | $671,499.78 |
DisclosureSEC source: 0001022079-21-000058 · wf-form4_161549827709752.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,152 F3 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2021. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:33 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Tax withholdingCommon Stock | 25,887 | $115.42 | $2,987,877.54 |
DisclosureSEC source: 0001022079-21-000060 · wf-form4_161549838956269.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,427 F1 · security: Represents an award of restricted share units granted on February 25, 2013. F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:33 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
GrantCommon Stock | 58,368 | $115.42 | $6,736,834.56 |
DisclosureSEC source: 0001022079-21-000060 · wf-form4_161549838956269.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,314 F1 · security: Represents an award of restricted share units granted on February 25, 2013. F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:29 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 684 | $115.42 | $78,947.28 |
DisclosureSEC source: 0001022079-21-000056 · wf-form4_161549814943604.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,802 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:29 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
GrantCommon Stock | 1,884 | $115.42 | $217,451.28 |
DisclosureSEC source: 0001022079-21-000056 · wf-form4_161549814943604.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,485 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:31 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 4,217 | $115.42 | $486,726.14 |
DisclosureSEC source: 0001022079-21-000058 · wf-form4_161549827709752.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,726 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:31 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantCommon Stock | 9,791 | $115.42 | $1,130,077.22 |
DisclosureSEC source: 0001022079-21-000058 · wf-form4_161549827709752.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,943 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:27 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 6,403 | $115.42 | $739,034.26 |
DisclosureSEC source: 0001022079-21-000054 · wf-form4_161549803034551.xml · nonDerivative · entry 2 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,792 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:27 UTC |
GUINAN MARKExecutive Vice President & CFO
|
GrantCommon Stock | 17,322 | $115.42 | $1,999,305.24 |
DisclosureSEC source: 0001022079-21-000054 · wf-form4_161549803034551.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,195 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:25 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Tax withholdingCommon Stock | 5,066 | $115.42 | $584,717.72 |
DisclosureSEC source: 0001022079-21-000052 · wf-form4_161549789475673.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,265 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:25 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantCommon Stock | 11,299 | $115.42 | $1,304,130.58 |
DisclosureSEC source: 0001022079-21-000052 · wf-form4_161549789475673.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,331 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:23 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 8,334 | $115.42 | $961,910.28 |
DisclosureSEC source: 0001022079-21-000050 · wf-form4_161549775337428.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,931 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:23 UTC |
Davis J. E.EVP, General Diagnostics
|
GrantCommon Stock | 16,570 | $115.42 | $1,912,509.40 |
DisclosureSEC source: 0001022079-21-000050 · wf-form4_161549775337428.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,265 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:20 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
Tax withholdingCommon Stock | 6,165 | $115.42 | $711,564.30 |
DisclosureSEC source: 0001022079-21-000048 · wf-form4_161549760802788.xml · nonDerivative · entry 2 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,250 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:20 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
GrantCommon Stock | 13,181 | $115.42 | $1,521,351.02 |
DisclosureSEC source: 0001022079-21-000048 · wf-form4_161549760802788.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,394 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:29 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 801 | $115.49 | $92,507.49 |
DisclosureSEC source: 0001022079-21-000046 · wf-form4_161463417669605.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,152 F1 · shares: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 30, 2020. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:41 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 806 | $121.19 | $97,679.14 |
DisclosureSEC source: 0001022079-21-000044 · wf-form4_161428928915885.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,695 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:36 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 103 | $121.19 | $12,482.57 |
DisclosureSEC source: 0001022079-21-000042 · wf-form4_161428895318755.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,601 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:39 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 750 | $116.95 | $87,712.50 |
DisclosureSEC source: 0001022079-21-000043 · wf-form4_161428913031496.xml · nonDerivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,953 F3 · shares: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on December 1, 2020. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:39 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 438 | $116.95 | $51,224.10 |
DisclosureSEC source: 0001022079-21-000043 · wf-form4_161428913031496.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,703 F3 · shares: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on December 1, 2020. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:39 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 455 | $121.19 | $55,141.45 |
DisclosureSEC source: 0001022079-21-000043 · wf-form4_161428913031496.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,141 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:34 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
Tax withholdingCommon Stock | 611 | $121.19 | $74,047.09 |
DisclosureSEC source: 0001022079-21-000041 · wf-form4_161428886233481.xml · nonDerivative · entry 2 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,213 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Tax withholdingCommon Stock | 3,319 | $121.19 | $402,229.61 |
DisclosureSEC source: 0001022079-21-000039 · wf-form4_161428867883226.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,946 F2 · security: Represents an award of restricted share units granted on February 25, 2013. F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:32 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 541 | $121.19 | $65,563.79 |
DisclosureSEC source: 0001022079-21-000040 · wf-form4_161428874135843.xml · nonDerivative · entry 2 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,873 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:30 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Tax withholdingCommon Stock | 524 | $121.19 | $63,503.56 |
DisclosureSEC source: 0001022079-21-000038 · wf-form4_161428858488018.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,032 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:41 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 1,250 | $121.15 | $151,437.50 |
DisclosureSEC source: 0001022079-21-000044 · wf-form4_161428928915885.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,501 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted share units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.